Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...
Lifestyle changes like reducing caffeine and managing fluid intake are recommended before using medications for overactive ...
While there is currently only one oral medication specifically approved for the treatment of interstitial cystitis, several off-label medications are used for this condition. Interstitial cystitis (IC ...
PRINCETON, N.J.--(BUSINESS WIRE)-- UroGen Pharma Ltd. (URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today ...